Connection
John Rumsfeld to United States Food and Drug Administration
This is a "connection" page, showing publications John Rumsfeld has written about United States Food and Drug Administration.
|
|
Connection Strength |
|
 |
|
 |
|
0.211 |
|
|
|
-
Tsai TT, Box TL, Gethoffer H, Noonan G, Varosy PD, Maddox TM, Fihn SD, Gross TP, Jesse RL, Rumsfeld JS. Feasibility of proactive medical device surveillance: the VA Clinical Assessment Reporting and Tracking (CART) program. Med Care. 2013 Mar; 51(3 Suppl 1):S57-61.
Score: 0.100
-
Rumsfeld JS, Peterson ED. Achieving meaningful device surveillance: from reaction to proaction. JAMA. 2010 Nov 10; 304(18):2065-6.
Score: 0.085
-
Carroll JD, Edwards FH, Marinac-Dabic D, Brindis RG, Grover FL, Peterson ED, Tuzcu EM, Shahian DM, Rumsfeld JS, Shewan CM, Hewitt K, Holmes DR, Mack MJ. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol. 2013 Sep 10; 62(11):1026-34.
Score: 0.025